SkyView Investment Advisors’s Enlivex Therapeutics ENLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12K Hold
10,000
﹤0.01% 288
2025
Q1
$10K Buy
+10,000
New +$10K ﹤0.01% 284